Previous studies have confirmed the occurrence of SUMO modification of HNRNPK at residue 422 and HNRNPK is primarily modified by SUMO1, but the functional significance of this SUMO modification in GBM remain unclear 18. The gene discussed is HNRNPK; the disease is glioblastoma.